Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 6/20 | 0.49 |
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | HASPIN | Q8TF76 | 8/20 | 0.37 |
| ▸ | DYRK2 | Q92630 | 3/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 5/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21168174 | 0.88 | DYRK1A (0.57) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL22808273 | 0.81 | DYRK1A (0.46) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL21168176 | 0.76 | ALKBH5 (0.53) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL20122849 | 0.76 | DYRK1A (0.45) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL3333888 | 0.73 | DYRK1A (0.59) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL20122851 | 0.71 | DYRK1A (0.47) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL21562559 | 0.68 | DYRK1A (0.65) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL28929340 | 0.68 | ACHE (0.65) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL24527888 | 0.67 | HASPIN (0.46) | DYRK1AACHEMAOABCHEHASPIN | |
| SCHEMBL24122035 | 0.67 | ADORA2A (0.42) | DYRK1AACHEMAOABCHEHASPIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10873039-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10873039-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | ORC3, LEF1, OCIAD1 | DYRK1A 4634/4885ACHE 1413/4885MAOA 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.